Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports.Check Now!

Hero Background

prader willi syndrome

What can an abnormality in the chromosome 15 results in Prader-Willi syndrome.

Prader-Willi Syndrome

A complex genetic condition, Prader-Willi syndrome (PWS) is a result of the loss of the functioning of genes in a particular region of chromosome 15. Genetic testing confirms the definitive diagnosis of the condition.

The hallmark of PWS is a constant sense of hunger and obesity, and it affects approximately 1 out of every 15,000 births and has standard treatment. Prader–Willi syndrome (PWS) is a complex and rare genetic disorder that affects multiple systems in the body. First described in 1956 by Swiss doctors Andrea Prader, Heinrich Willi, and Alexis Labhart, the syndrome is caused by a loss of function of specific genes on the paternal copy of chromosome 15 (15q11-q13). This region contains genes that are normally only active on the paternal chromosome, so if they're missing or inactive, the corresponding maternal genes cannot compensate.

The newsletter by DelveInsight offers a brief overview of the indication, its subtypes, and its symptoms. It focuses on the epidemiological trends segmented into geographies in the 7MM, ethnicity, gender, total, and diagnosed cases.

The newsletter focuses on its clients and readers, helping them gain insights into market trends and the pipeline therapies that shall veer the PWS market in a positive direction.

For rich insights into the Prader-Willi syndrome market landscape, fill the form and get the newsletter right into your virtual mailbox.

Embrace the hassle-free way of staying updated by subscribing to our emailer's list. Catch up with all the updates and trends in the Life Science industry in your inbox .

Stay Connected.

Know More About Whats Covered:

  • Indication overview
  • Epidemiological trends
  • Treatment approaches
  • Key Companies
  • Pipeline drugs
  • Support from International organizations
  • Top conferences
  • R&D in the field
  • Collaborations and deals in the domain

More Newsletter Whitepaper